A new report suggests that differences in albuminuria might contribute to disparities in susceptibility to nephropathy in African American and white individuals. Interpretation of this finding requires consideration of renal histology, clinical trials and genetic studies. These factors indicate that a far more complex scenario is likely to exist than previously thought.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
McClellan, W. M. et al. Albuminuria and racial disparities in the risk for ESRD. J. Am. Soc. Nephrol. 22, 1721–1728 (2011).
Friedman, D., Kozlitina, J., Genovese, G. & Jog, P. APOL1 genotype identifies African Americans at high risk of non-diabetic kidney disease in the Dallas Heart Study. J. Am. Soc. Nephrol. (in press).
Divers, J. et al. Ethnic differences in the relationship between albuminuria and calcified atherosclerotic plaque: the African American-Diabetes Heart Study. Diabetes Care 33, 131–138 (2010).
Murea, M. & Freedman, B. I. Essential hypertension and risk of nephropathy: a reappraisal. Curr. Opin. Nephrol. Hypertens. 19, 235–241 (2010).
Shulman, N. B. et al. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 13, I80–I93 (1989).
Walker, W. G., Neaton, J. D., Cutler, J. A., Neuwirth, R. & Cohen, J. D. Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group. JAMA 268, 3085–3091 (1992).
Appel, L. J. et al. for the AASK Collaborative Research Group. Intensive blood-pressure control in hypertensive chronic kidney disease. N. Engl. J. Med. 363, 918–929 (2010).
Genovese, G. et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329, 841–845 (2010).
Friedman, D. J. & Pollak, M. R. Genetics of kidney failure and the evolving story of APOL1. J. Clin. Invest. 121, 3367–3374 (2011).
Reeves-Daniel, A. M. et al. The APOL1 gene and allograft survival after kidney transplantation. Am. J. Transplant. 11, 1025–1030 (2011).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Freedman, B., Bowden, D. Race, renal disease and albuminuria. Nat Rev Nephrol 7, 679–680 (2011). https://doi.org/10.1038/nrneph.2011.154
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2011.154
